Midwest Trust 13F: Cuts Synopsys (SNPS) Stake by $8.6M

Synopsys, Inc. (SNPS) business photo

Key Points

  • Midwest Trust sold 19,690 shares of Synopsys, Inc. SNPS during the quarter, cutting its position by 94.2% to end with 1,213 shares worth about $527,582.
  • Synopsys closed at $422.48 on the filing date, trading below its 50-day moving average of $430.30 and well off its 52-week high of $539.48.
  • Wall Street maintains a consensus strong buy rating on the software maker, with a mean price target of $586.95 ahead of its December 9, 2026 earnings report.

Get Synopsys text alerts

We text you when insiders, Congress, analysts or big funds move on $SNPS.

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated Synopsys, Inc. alert may contain errors. Disclosures

Midwest Trust cut its stake in Synopsys, Inc. SNPS by 19,690 shares during the third quarter, according to a Form 13F filing with the SEC on October 22, 2026. The reduction left the firm holding 1,213 shares valued at approximately $527,582.

SNPS Synopsys, Inc.
$427.88 -10.94% year to date
Daily close · Oct 22, 2026

What Changed in Midwest Trust's Synopsys Position

Prior to the recent filing, Midwest Trust owned 20,903 shares of the software infrastructure provider. By trimming its holdings by a 94.2% margin, the trust sharply lowered its exposure to the chip design software maker. Institutional filings provide a look at portfolio adjustments after a quarter concludes, though they do not show the exact dates trades took place during that three-month window.

Other Institutional Activity in Synopsys

Other major institutional investors adjusted their positions in Synopsys around the same period. Nvidia Corp kept its holdings steady at 4,821,717 shares worth about $2,037,079,051 with no change in units. Meanwhile, Van Eck Associates Corporation grew its holdings by 569,711 shares, ending with 3,457,249 shares worth about $1,460,618,595, a 19.7% increase.

Synopsys, Inc. Stock Down 5.6%

Synopsys shares recently traded around $422.63 as of October 23, 2026, sitting right near the $422.48 close recorded on the day of the filing. The stock trades below its 50-day moving average of $430.30 and its 200-day moving average of $445.46. Shares have ranged from a 52-week low of $362.55 to a 52-week high of $539.48 over the past year.

Recent Earnings

For the trailing twelve months, Synopsys reported $9.42 billion in revenue and earnings of $5.66 per share. The company posted a net profit margin of 11.4% and a return on equity of 3.7%. Its next quarterly earnings release is scheduled for December 9, 2026.

Insider Buying and Selling at Synopsys, Inc.

Company insiders executed several sales of Synopsys stock ahead of the filing. Officer and Director Geus Aart J De disposed of 49,641 shares worth $21,379,539 on September 1, 2026. Chief Executive Officer Sassine E Ghazi sold 14,604 shares at a price of $374.88 for a total value of $5,474,683 on September 15, 2026. Officer Sudhindra Kankanwadi sold 12,170 shares valued at $6,039,340 on October 6, 2026. Finally, General Counsel Janet Lee sold 1,143 shares worth $574,685 on October 6, 2026.

Analysts Set New Price Targets

Analyst firms remain largely positive on the software developer. On October 1, 2026, Wells Fargo maintained an Overweight rating while raising its price target to $540.00 from $475.00. Keybanc kept an Overweight rating on October 1, 2026, lifting its target from $600.00 to $605.00. Rosenblatt maintained a Buy rating on October 1, 2026, and raised its target to $620.00 from $575.00. Needham kept a Buy rating on October 12, 2026, moving its target to $620.00 from $580.00. Morgan Stanley maintained an Overweight rating on October 20, 2026, pushing its target to $574.00 from $500.00. Overall, analysts hold a consensus strong buy rating with a mean price target of $586.95 across 25 opinions.

About Synopsys

Synopsys, Inc. builds software and design automation tools used by semiconductor and electronics companies to create advanced computer chips and electronic systems. Headquartered in Sunnyvale, California, the company operates through design automation and design IP segments, helping engineers verify complex chip layouts before manufacturing.

Bottom Line

Investors tracking Midwest Trust will look to future SEC filings to see if the firm continues to scale back its software holdings. The company's upcoming earnings report on December 9, 2026, will provide updated financial metrics for the business.

Source: Midwest Trust's 13F filing on $SNPS (Oct 22, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Written by software, not financial advice. How we make alerts

Get $SNPS trade alerts by text

SMS Terms

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Full terms and conditions